CPI Aerostructures, Inc. — Q1 2023 Form 10-Q
Reporting period: Three months ended March 31, 2023. CPI Aero manufactures structural aircraft parts and aerosystems for commercial and defense markets, and provides related engineering, program, supply-chain, and MRO services. Most revenue comes from long-term U.S. government and military-contractor programs.
Financial performance and position
| Metric | Q1 2023 / March 31, 2023 | Comparable / prior period |
|---|---|---|
| Revenue | $22.0 million | $20.1 million, up 9.3% |
| Gross profit / margin | $4.7 million / 21.2% | $3.4 million / 17.1% |
| Operating income | $1.8 million | $0.3 million |
| Interest expense | $0.6 million | $0.3 million |
| Net income (loss) | $1.0 million; diluted EPS $0.08 | $(33,000); diluted EPS $(0.00) |
| Cash from operations | $0.9 million | $(2.4) million |
| Cash | $4.0 million | $3.8 million at December 31, 2022 |
| Working capital | $13.7 million | $12.9 million at December 31, 2022 |
| Total assets / liabilities | $62.3 million / $56.8 million | $59.4 million / $55.3 million at December 31, 2022 |
Revenue growth reflected higher Raytheon Next Generation Jammer pod and Lockheed Martin F-16 program activity, partly offset by declines in several other programs. Aerosystems revenue increased to $9.6 million from $6.7 million; kitting and supply-chain management revenue declined to $2.4 million from $4.3 million. Gross margin improved despite negative net contract estimate adjustments of $721,000, compared with positive adjustments of $318,000 a year earlier.
Operating cash flow was positive, but contract assets increased $3.0 million to $30.4 million, contributing to cash-flow needs. Investing cash outflow was $44,000; financing cash outflow was $698,000, primarily debt repayments and debt issuance costs. The company had $21.0 million outstanding under its revolving loan and $983,000 of term-loan principal outstanding. Both facilities bore interest at 11.5% at quarter-end; the credit facility is secured by company assets.
Material changes, outlook, and risks
- Credit amendment: A March 2023 amendment extended the credit facility maturity to November 30, 2024, while scheduling step-downs in the maximum revolving balance beginning October 2023. The term loan principal was due to be repaid by June 30, 2023. The company reported no availability for additional revolving borrowings.
- Backlog: Total backlog was $515.8 million at March 31, 2023, versus $514.5 million at year-end. Funded backlog declined to $113.3 million from $122.1 million. Approximately 98% of total backlog was attributable to government and military-contractor contracts. Backlog is substantially subject to termination or rescheduling, and funding may be appropriated periodically.
- Management outlook: Management believes available resources are sufficient for working-capital needs for at least 12 months from issuance of the financial statements. No specific revenue or earnings guidance is provided. Management noted working-capital needs depend on program awards and customer and supplier payment timing.
- Contract and liquidity risks: The business funds materials and production before billing on some contracts; revenue recognition depends on estimates of costs and contract progress. Delays, cancellations, cost-estimate changes, or unrecoverable upfront costs could affect margins and liquidity. Fixed-price contracts expose the company to inflation, labor, supply-chain, and cost risks. The revolving facility has no current borrowing availability and bears a high stated interest rate.
- Customer concentration: Two customers represented 36% and 28% of Q1 revenue. Significant portions of contract assets and receivables were also concentrated among a small number of customers.
- Litigation: The $3.6 million class-action settlement was approved and the case terminated in March; the settlement amount was transferred from escrow to the plaintiff on May 5, 2023. At quarter-end, the balance sheet still showed a matching $3.6 million settlement obligation and insurance receivable. A proposed derivative-action settlement involving $585,000 of attorneys’ fees and governance reforms had preliminary approval but remained subject to final court approval.
- Controls: Management reported material weaknesses in internal control over financial reporting as of December 31, 2022 and planned remediation during 2023. No material control changes were reported for the quarter.
- Other unusual items: Q1 2022 included $771,834 of severance expense and $263,148 of restricted-stock forfeiture credits in SG&A, affecting year-over-year comparisons. Q1 2023 stock-based compensation rose to $339,000 from $26,000.
Key facts for investors to verify
- Progress in converting the large, predominantly unfunded backlog into funded orders, revenue, billings, and cash receipts.
- Compliance with credit covenants and the ability to meet scheduled facility reductions, term-loan repayments, and amendment-fee payments.
- Whether contract-asset growth and customer payment timing allow operating cash flow to remain positive.
- Margin sensitivity to contract estimate revisions, program execution, labor and procurement costs, and fixed-price commitments.
- Final approval and resolution of the derivative litigation settlement, and completion of internal-control remediation.
- The filing’s EPS discussion contains a basic weighted-average share count that differs slightly from the financial-statement table; confirm the intended figure against the company’s filed data.